Pages that link to "Q80048628"
Jump to navigation
Jump to search
The following pages link to Combretastatin A-1 phosphate potentiates the antitumor activity of carboplatin and paclitaxel in a severe combined immunodeficiency disease (SCID) mouse model of human ovarian carcinoma (Q80048628):
Displaying 4 items.
- Stabilizing versus destabilizing the microtubules: a double-edge sword for an effective cancer treatment option? (Q26781365) (← links)
- A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer (Q33389126) (← links)
- Tumorgrafts as in vivo surrogates for women with ovarian cancer. (Q37626455) (← links)
- Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies. (Q38722976) (← links)